Guided Therapeutics Inc
OTC:GTHP
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| US |
|
Guided Therapeutics Inc
OTC:GTHP
|
33.9m USD |
Loading...
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
186.1B USD |
Loading...
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
178B USD |
Loading...
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
141.5B USD |
Loading...
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
137.7B USD |
Loading...
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
133B USD |
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
57.6B USD |
Loading...
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
47.1B EUR |
Loading...
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
51.2B USD |
Loading...
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
48B USD |
Loading...
|
|
| US |
|
Resmed Inc
NYSE:RMD
|
37.3B USD |
Loading...
|
Market Distribution
| Min | -4 418 600% |
| 30th Percentile | -9.6% |
| Median | 3.1% |
| 70th Percentile | 11.3% |
| Max | 1 135 400% |
Other Profitability Ratios
Guided Therapeutics Inc
Glance View
Guided Therapeutics, Inc. engages in the development of medical devices. The company is headquartered in Norcross, Georgia. The firm is focused on selling and marketing of its LuViva advanced cervical scan non-invasive cervical cancer detection device. The underlying technology of LuViva primarily relates to the use of biophotonics for the non-invasive detection of cancers. LuViva is designed to identify cervical cancers and precancers painlessly, non-invasively and at the point of care by scanning the cervix with light, then analyzing the reflected and fluorescent light. The firm focuses on two primary applications for LuViva as a cancer screening tool, and triage traditional screening. Screening is for cervical cancer represents the practice of diagnostic medicine. The firm is also focused on the extension of its cancer detection technology into other cancers, including esophageal.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Guided Therapeutics Inc is -2 297.5%, which is above its 3-year median of -36 800%.
Over the last 3 years, Guided Therapeutics Inc’s Net Margin has increased from -2 630% to -2 297.5%. During this period, it reached a low of -261 300% on Mar 31, 2025 and a high of -2 297.5% on Jul 30, 2025.
